title: An autopsy case of diffuse panbronchiolitis associated with lung cancer.
abstract: The prognosis of diffuse panbronchiolitis (DPB) has been remarkably improved after the development of low-dose erythromycin therapy, possibly due to anti-inflammatory rather than anti-infective mechanisms. Interestingly, DPB associated with lung cancer is quite rare. Here, we report an autopsy case of DPB who developed lung cancer after a long successful therapy with low-dose erythromycin.
authors.affiliation: Second Department of Internal Medicine, School of Medicine, Hiroshima University.
authors.forename: S
authors.initials: S
authors.lastname: Ishioka
authors.forename: K
authors.initials: K
authors.lastname: Hiyama
authors.forename: T
authors.initials: T
authors.lastname: Nishisaka
authors.forename: M
authors.initials: M
authors.lastname: Yokozaki
authors.forename: H
authors.initials: H
authors.lastname: Maeda
authors.forename: A
authors.initials: A
authors.lastname: Maeda
authors.forename: Y
authors.initials: Y
authors.lastname: Jougasaki
authors.forename: M
authors.initials: M
authors.lastname: Yamakido
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000175:diagnosis; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001344:Autopsy; D001988:Bronchiolitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000175:diagnosis; D011379:Prognosis
chemical_list: D000900:Anti-Bacterial Agents; D004917:Erythromycin